Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 6, 2005, Pages 2276-2282

  Ciofu, Oana ^a   Riis, Bente ^b   Pressler, Tacjana ^b   Poulsen, Henrik Enghusen ^b   Høiby, Niels ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANTIBIOTIC AGENT; BACTERIAL DNA; GUANINE; REACTIVE OXYGEN METABOLITE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CYSTIC FIBROSIS; LUNG INFECTION; NEUTROPHIL; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PERSISTENT INFECTION; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADULT; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DEOXYGUANOSINE; DRUG RESISTANCE, BACTERIAL; HUMANS; INFLAMMATION; LUNG DISEASES; MUTATION; OXIDATIVE STRESS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM;

EID: 19544386997     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.6.2276-2282.2005     Document Type: Article

References (39)

1. Au, K. G., S. Clark, J. H. Miller, and P. Modrich. 1989. Escherichia coli mutY gene encodes an adenine glycosylase active on G-A mispairs. Proc. Natl. Acad. Sci. USA 86:8877-8881.
2. Brown, R. K., and F. J. Kelly. 1994. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr. Res. 36:487-493.
3. Chopra, I., A. J. O'Neill, and K. Miller. 2003. The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist. Update 6:137-145.
4. Ciofu, O., B. Giwercman, S. S. Pedersen, and N. Høiby. 1994. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center. APMIS 102:674-680.
5. Ciofu, O., T. Jensen, T. Pressler, H. K. Johansen, C. Koch, and N. Høiby. 1996. Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to beta-lactam antibiotics. Clin. Microbiol. Infect. 2:91-98.
6. Döring, G., W. Goldstein, K. Bolzenhart, A. Kharazmi, P. O. Schiøtz, N. Høiby, and M. Dasgupta. 1986. Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease. Clin. Exp. Immunol. 64:597-605.
7. Frederiksen, B., C. Koch, and N. Høiby. 1999. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr. Pulmonol. 28:159-166.
8. Giwercman, B., P. A. Lambert, V. T. Rosdahl, G. H. Shand, and N. Høiby. 1990. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains. J. Antimicrob. Chemother. 26:247-259.
9. Hammer, M. C., A. L. Baltch, N. T. Sutphen, R. P. Smith, and J. V. Conroy. 1981. Pseudomonas aeruginosa: quantitation of maximum phagocytic and bactericidal capabilities of normal human granulocytes. J. Lab. Clin. Med. 98:938-948.
10. Hammerschlag, M. R., L. Harding, A. Macone, A. L. Smith, and D. A. Goldmann. 1980. Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent. J. Clin. Microbiol. 11:552-557.
11. Høiby, N. 1976. The serology of Pseudomonas aeruginosa analysed by means of quantitative immunoelectrophoretic methods. Acta Pathol. Microbiol. Scand. Sect. C 84C:372-382.
12. Høiby, N., L. Jacobsen, B. A. Jorgensen, E. Lykkegaard, and B. Weeke. 1974. Pseudomonas aeruginosa infection in cystic fibrosis. Occurrence of precipitating antibodies against Pseudomonas aeruginosa in relation to the concentration of sixteen serum proteins and the clinical and radiographical status of the lungs. Acta Paediatr. Scand. 63:843-848.
13. Hull, J., P. Vervaart, K. Grimwood, and P. Phelan. 1997. Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax 52:557-560.
14. Jensen, E. T., A. Kharazmi, K. Lam, J. W. Costerton, and N. Høiby. 1990. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms. Infect. Immun. 58:2383-2385.
15. Jensen, T., A. Kharazmi, P. O. Schiøtz, H. Nielsen, S. Stenvang Pedersen, G. Stafanger, C. Koch, and N. Høiby. 1988. Effect of oral N-acetylcysteine administration on human blood neutrophil and monocyte function. APMIS 96:62-67.
16. Lagrange-Puget, M., I. Durieu, R. Ecochard, F. Abbas-Chorfa, J. Drai, J. P. Steghens, Y. Pacheco, D. Vital-Durand, and G. Bellon. 2004. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation. Pediatr. Pulmonol. 38:43-49.
17. LeClerc, J. E., B. Li, W. L. Payne, and T. A. Cebula. 1996. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274: 1208-1211.
18. Maki, H., and M. Sekiguchi. 1992. MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis. Nature 355:273-275.
19. Mathee, K., O. Ciofu, C. Sternberg, P. W. Lindum, J. I. Campbell, P. Jensen, A. H. Johnsen, M. Givskov, D. E. Ohman, S. Molin, N. Høiby, and A. Kharazmi. 1999. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145:1349-1357.
20. Michaels, M. L., C. Cruz, A. P. Grollman, and J. H. Miller. 1992. Evidence that MutY and MutM combine to prevent mutations by an oxidatively damaged form of guanine in DNA. Proc. Natl. Acad. Sci. USA 89:7022-7025.
21. Michaels, M. L., and J. H. Miller. 1992. The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxoguanine). J. Bacteriol. 174:6321-6325.
22. Miller, J. H. 1996. Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair. Annu. Rev. Microbiol. 50:625-643.
23. Miller, J. H., A. Suthar, J. Tai, A. Yeung, C. Truong, and J. L. Stewart. 1999. Direct selection for mutators in Escherichia coli. J. Bacteriol. 181:1576-1584.
24. Ojeniyi, B., N. Høiby, and V. T. Rosdahl. 1991. Genome fingerprinting as a typing method used on polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients. APMIS 99:492-498.
25. Oliver, A., F. Baquero, and J. Blazquez. 2002. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol. Microbiol. 43:1641-1650.
26. Oliver, A., R. Canton, P. Campo, F. Baquero, and J. Blazquez. 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251-1254.
27. Oliver, A., B. R. Levin, C. Juan, F. Baquero, and J. Blazquez. 2004. Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections. Antimicrob. Agents Chemother. 48:4226-4233.
28. Oliver, A., J. M. Sanchez, and J. Blazquez. 2002. Characterization of the GO system of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 217:31-35.
29. Prunier, A. L., B. Malbruny, M. Laurans, J. Brouard, J. F. Duhamel, and R. Leclercq. 2003. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J. Infect. Dis. 187:1709-1716.
30. Radman, M., F. Taddei, and I. Matic. 2000. Evolution-driving genes. Res. Microbiol. 151:91-95.
31. Roman, F., R. Canton, M. Perez-Vazquez, F. Baquero, and J. Campos. 2004. Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains. J. Clin. Microbiol. 42:1450-1459.
32. Romling, U., and B. Tummler. 2000. Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. J. Clin. Microbiol. 38:464-465.
33. Roum, J. H., Z. Borok, N. G. McElvaney, G. J. Grimes, A. D. Bokser, R. Buhl, and R. G. Crystal. 1999. Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis. J. Appl. Physiol. 87:438-443.
34. Sethi, S., and T. F. Murphy. 2001. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin. Microbiol. Rev. 14:336-363.
35. Stafanger, G., and C. Koch. 1989. N-Acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: clinical score, spirometry and ciliary motility. Eur. Respir. J. 2:234-237.
36. Stewart, P. S., F. Roe, J. Rayner, J. G. Elkins, Z. Lewandowski, U. A. Ochsner, and D. J. Hassett. 2000. Effect of catalase on hydrogen peroxide penetration into Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 66:836-838.
37. Tajiri, T., H. Maki, and M. Sekiguchi. 1995. Functional cooperation of MutT, MutM and MutY proteins in preventing mutations caused by spontaneous oxidation of guanine nucleotide in Escherichia coli. Mutat. Res. 336:257-267.
38. Tchou, J., H. Kasai, S. Shibutani, M. H. Chung, J. Laval, A. P. Grollman, and S. Nishimura. 1991. 8-Oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc. Natl. Acad. Sci. USA 88:4690-4694.
39. Wood, L. G., D. A. Fitzgerald, P. G. Gibson, D. M. Cooper, C. E. Collins, and M. L. Garg. 2001. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J. Am Coll. Nutr. 20:157-165.